The disruption of the OPN interactions also sensitizes ALL cells to treatment as the co-treatment of chemotherapy with OPN neutralization was more effective than chemotherapy alone, and may serve as a therapeutic potential [104]. The gene discussed is SPP1; the disease is acute lymphoblastic leukemia.